Morgan Stanley’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-275,990
| Closed | -$2.65M | – | 8328 |
|
|
2024
Q4 | $2.65M | Sell |
275,990
-263,020
| -49% | -$2.52M | ﹤0.01% | 4502 |
|
|
2024
Q3 | $1.54M | Buy |
539,010
+175,729
| +48% | +$503K | ﹤0.01% | 4796 |
|
|
2024
Q2 | $1.06M | Sell |
363,281
-105,295
| -22% | -$307K | ﹤0.01% | 4924 |
|
|
2024
Q1 | $1.49M | Sell |
468,576
-214,702
| -31% | -$685K | ﹤0.01% | 4738 |
|
|
2023
Q4 | $2.3M | Buy |
683,278
+404,120
| +145% | +$1.36M | ﹤0.01% | 4850 |
|
|
2023
Q3 | $664K | Sell |
279,158
-276,758
| -50% | -$659K | ﹤0.01% | 5025 |
|
|
2023
Q2 | $978K | Buy |
555,916
+74,090
| +15% | +$130K | ﹤0.01% | 4846 |
|
|
2023
Q1 | $1.48M | Buy |
481,826
+375,739
| +354% | +$1.16M | ﹤0.01% | 4628 |
|
|
2022
Q4 | $562K | Buy |
106,087
+36,628
| +53% | +$194K | ﹤0.01% | 5182 |
|
|
2022
Q3 | $245K | Sell |
69,459
-3,114
| -4% | -$11K | ﹤0.01% | 5634 |
|
|
2022
Q2 | $188K | Buy |
72,573
+19,908
| +38% | +$51.6K | ﹤0.01% | 5934 |
|
|
2022
Q1 | $236K | Buy |
52,665
+7,857
| +18% | +$35.2K | ﹤0.01% | 5827 |
|
|
2021
Q4 | $306K | Buy |
44,808
+9,853
| +28% | +$67.3K | ﹤0.01% | 5831 |
|
|
2021
Q3 | $254K | Buy |
34,955
+13,893
| +66% | +$101K | ﹤0.01% | 5873 |
|
|
2021
Q2 | $212K | Buy |
21,062
+20,496
| +3,621% | +$206K | ﹤0.01% | 5986 |
|
|
2021
Q1 | $6K | Sell |
566
-9,358
| -94% | -$99.2K | ﹤0.01% | 7074 |
|
|
2020
Q4 | $109K | Buy |
9,924
+7,850
| +378% | +$86.2K | ﹤0.01% | 5874 |
|
|
2020
Q3 | $18K | Buy |
+2,074
| New | +$18K | ﹤0.01% | 6103 |
|